Halo operates an R&D collaboration platform that combines a network of scientists at universities, national labs and startups, a marketplace where companies post RFPs and Open Calls, and a suite of software tools that create a searchable private content library. Companies create partnering pages, post requests for proposals or open calls, and offer resources (funding, expertise, technologies, facilities, data, compounds) for scientists to respond with short non-confidential proposals. The platform is used across industries including biopharma, medical devices, consumer goods and agriculture, with RFPs to date on topics like sustainable packaging, dialysis water safety, and rare disease diagnostics. Led by CEO Kevin Leland, Halo will use the newly raised capital to grow the team, develop additional collaboration features and tools, and expand its network of scientists globally. The company raised $2.6M in Seed funding and intends to continue building its marketplace and software capabilities.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2022